Open access · CC-BY
via OpenAlex
Resveratrol-mediated SIRT-1 Interactions with p300 Modulate Receptor Activator of NF-κB Ligand (RANKL) Activation of NF-κB Signaling and Inhibit Osteoclastogenesis in Bone-derived Cells
Mehdi Shakibaei, Constanze Buhrmann, Ali Mobasheri
Journal of Biological Chemistry · 2011 · ▲ 226 citations
Epigenetic alterations
Altered intercellular communication
Chronic inflammation
Cell culture / in vitro
In vitro
Abstract
Resveratrol is a polyphenolic phytoestrogen that has been shown to exhibit potent anti-oxidant, anti-inflammatory, and anti-catabolic properties. Increased osteoclastic and decreased osteoblastic activities result in bone resorption and loss of bone mass. These changes have been implicated in pathological processes in rheumatoid arthritis and osteoporosis. Receptor activator of NF-κB ligand (RANKL), a member of the TNF superfamily, is a major mediator of bone loss. In this study, we investigated the effects of resveratrol on RANKL during bone morphogenesis in high density bone cultures in vitro. Untreated bone-derived cell cultures produced well organized bone-like structures with a bone-specific matrix. Treatment with RANKL induced formation of tartrate-resistant acid phosphatase-positive multinucleated cells that exhibited morphological features of osteoclasts. RANKL induced NF-κB activation, whereas pretreatment with resveratrol completely inhibited this activation and suppressed the activation of IκBα kinase and IκBα phosphorylation and degradation. RANKL up-regulated p300 (a histone acetyltransferase) expression, which, in turn, promoted acetylation of NF-κB. Resveratrol inhibited RANKL-induced acetylation and nuclear translocation of NF-κB in a time- and concentration-dependent manner. In addition, activation of Sirt-1 (a histone deacetylase) by resveratrol induced Sirt-1-p300 association in bone-derived and preosteoblastic cells, leading to deacetylation of RANKL-induced NF-κB, inhibition of NF-κB transcriptional activation, and osteoclastogenesis. Co-treatment with resveratrol activated the bone transcription factors Cbfa-1 and Sirt-1 and induced the formation of Sirt-1-Cbfa-1 complexes. Overall, these results demonstrate that resveratrol-activated Sirt-1 plays pivotal roles in regulating the balance between the osteoclastic versus osteoblastic activity result in bone formation in vitro thereby highlighting its therapeutic potential for treating osteoporosis and rheumatoid arthritis-related bone loss.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1074/jbc.m110.198713
- Canonical
- link ↗
- Fetched
- 2026-10-11 MST
Cite this
APA
Shakibaei, M., Buhrmann, C., & Mobasheri, A. (2011). Resveratrol-mediated SIRT-1 Interactions with p300 Modulate Receptor Activator of NF-κB Ligand (RANKL) Activation of NF-κB Signaling and Inhibit Osteoclastogenesis in Bone-derived Cells. <em>Journal of Biological Chemistry</em>. https://doi.org/10.1074/jbc.m110.198713
Vancouver
Shakibaei M, Buhrmann C, Mobasheri A. Resveratrol-mediated SIRT-1 Interactions with p300 Modulate Receptor Activator of NF-κB Ligand (RANKL) Activation of NF-κB Signaling and Inhibit Osteoclastogenesis in Bone-derived Cells. Journal of Biological Chemistry. 2011. doi:10.1074/jbc.m110.198713.
BibTeX
@article{mehdi2011Resver,
title = {Resveratrol-mediated SIRT-1 Interactions with p300 Modulate Receptor Activator of NF-κB Ligand (RANKL) Activation of NF-κB Signaling and Inhibit Osteoclastogenesis in Bone-derived Cells},
author = {Mehdi Shakibaei and Constanze Buhrmann and Ali Mobasheri},
journal = {Journal of Biological Chemistry},
year = {2011},
doi = {10.1074/jbc.m110.198713},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Bioengineered 2022
Open access · CC-BY
Effects of urolithin A on osteoclast differentiation induced by receptor activator of nuclear factor-κB ligand via bone morphogenic protein 2
Journal of Biological Chemistry 2012
Open access · CC-BY
Resveratrol Modulates Interleukin-1β-induced Phosphatidylinositol 3-Kinase and Nuclear Factor κB Signaling Pathways in Human Tenocytes
PLoS ONE 2012
Open access · CC-BY
Resveratrol Mediated Modulation of Sirt-1/Runx2 Promotes Osteogenic Differentiation of Mesenchymal Stem Cells: Potential Role of Runx2 Deacetylation
Aging Cell 2018
Open access · CC-BY
Micro RNA ‐31a‐5p from aging BMSC s links bone formation and resorption in the aged bone marrow microenvironment
Injury 2016
Preprint · CC-BY
Bone mechanical properties and changes with osteoporosis
Clinical Therapeutics 2015
Citation only